Jerome D. Goldberg

Array ( [id] => 3760685 [patent_doc_number] => 05843890 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Antibiotic GE 2270 factors B.sub.1, B.sub.2, C.sub.1, C.sub.2, D.sub.1, D.sub.2, E and T' [patent_app_type] => 1 [patent_app_number] => 8/462997 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10272 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1834 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843890.pdf [firstpage_image] =>[orig_patent_app_number] => 462997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3545061 [patent_doc_number] => 05554637 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-10 [patent_title] => 'Use of leflunomide for inhibiting interleukin 1 alpha' [patent_app_type] => 1 [patent_app_number] => 8/462916 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1952 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/554/05554637.pdf [firstpage_image] =>[orig_patent_app_number] => 462916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3986903 [patent_doc_number] => 05985274 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Antibiotic 10381A.sub.1 and process for the preparation of antibiotics 10381B' [patent_app_type] => 1 [patent_app_number] => 8/462081 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9566 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985274.pdf [firstpage_image] =>[orig_patent_app_number] => 462081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648276 [patent_doc_number] => 05684004 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Triaryl-ethylene derivatives' [patent_app_type] => 1 [patent_app_number] => 8/463792 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14717 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/684/05684004.pdf [firstpage_image] =>[orig_patent_app_number] => 463792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3984472 [patent_doc_number] => 05958980 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Immunopotentiatory agent and physiologically acceptable salts thereof' [patent_app_type] => 1 [patent_app_number] => 8/458911 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6401 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958980.pdf [firstpage_image] =>[orig_patent_app_number] => 458911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3706297 [patent_doc_number] => 05654287 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Method of treating cancer by conjunctive therapy with N,N.sup.1 -bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent' [patent_app_type] => 1 [patent_app_number] => 8/460482 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4027 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654287.pdf [firstpage_image] =>[orig_patent_app_number] => 460482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4032093 [patent_doc_number] => 05994362 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Method of treatment for prostatic cancer' [patent_app_type] => 1 [patent_app_number] => 8/459063 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49252 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994362.pdf [firstpage_image] =>[orig_patent_app_number] => 459063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3701092 [patent_doc_number] => 05646124 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Method of treating cancer by conjunctive therapy with N,N\'-bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent' [patent_app_type] => 1 [patent_app_number] => 8/458596 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4029 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646124.pdf [firstpage_image] =>[orig_patent_app_number] => 458596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4097453 [patent_doc_number] => 06096786 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Immunopotentiatory agent and physiologically acceptable salts thereof' [patent_app_type] => 1 [patent_app_number] => 8/460207 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6330 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096786.pdf [firstpage_image] =>[orig_patent_app_number] => 460207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3727124 [patent_doc_number] => 05635218 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Method of treating cancer by conjunctive therapy with N,N\'-bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent' [patent_app_type] => 1 [patent_app_number] => 8/460017 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4030 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635218.pdf [firstpage_image] =>[orig_patent_app_number] => 460017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3514749 [patent_doc_number] => 05512553 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-30 [patent_title] => '7-(substituted)-8-(substituted)-9-(substituted amino)-6-demethyl-6-deoxytetracyclines' [patent_app_type] => 1 [patent_app_number] => 8/454966 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67983 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 615 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/512/05512553.pdf [firstpage_image] =>[orig_patent_app_number] => 454966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3697055 [patent_doc_number] => 05674490 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Antibiotic GE1655 complex and its factors A, B, and C' [patent_app_type] => 1 [patent_app_number] => 8/456010 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8286 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674490.pdf [firstpage_image] =>[orig_patent_app_number] => 456010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770567 [patent_doc_number] => 05849738 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => '1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents' [patent_app_type] => 1 [patent_app_number] => 8/453329 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 13932 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 321 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849738.pdf [firstpage_image] =>[orig_patent_app_number] => 453329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695985 [patent_doc_number] => 05661155 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Treatment of cancer with pharmaceutically active benzoquinazoline compounds' [patent_app_type] => 1 [patent_app_number] => 8/452337 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63632 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661155.pdf [firstpage_image] =>[orig_patent_app_number] => 452337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658504 [patent_doc_number] => 05658945 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Urethanes and ureas that induce cytokine production' [patent_app_type] => 1 [patent_app_number] => 8/449968 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19477 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 373 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658945.pdf [firstpage_image] =>[orig_patent_app_number] => 449968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3683170 [patent_doc_number] => 05633280 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Urethanes and ureas that induce cytokine production' [patent_app_type] => 1 [patent_app_number] => 8/451085 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19823 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 371 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633280.pdf [firstpage_image] =>[orig_patent_app_number] => 451085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3526851 [patent_doc_number] => 05541191 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-30 [patent_title] => 'Rapamycin amidino carbamates' [patent_app_type] => 1 [patent_app_number] => 8/448866 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4345 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 553 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/541/05541191.pdf [firstpage_image] =>[orig_patent_app_number] => 448866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728402 [patent_doc_number] => 05670502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Method of tumor treatment' [patent_app_type] => 1 [patent_app_number] => 8/448705 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 12263 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670502.pdf [firstpage_image] =>[orig_patent_app_number] => 448705 [rel_patent_id] =>[rel_patent_doc_number] =>)